Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Histologically-confirmed Malignancies”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Not Yet RecruitingNCT07439172
What this trial is testing

Pre-Radiation Chemotherapy for Newly Diagnosed High-Grade Glioma.

Who this might be right for
High Grade GliomasGlioblastomaAstrocytoma+1 more
The Cooper Health System 70
Testing effectiveness (Phase 2)Study completedNCT00668811
What this trial is testing

Sutent Adjunctive Treatment of Differentiated Thyroid Cancer

Who this might be right for
Papillary Thyroid CancerFollicular Thyroid CancerDifferentiated Thyroid Cancer
Medstar Health Research Institute 23
Early research (Phase 1)Study completedNCT00687934
What this trial is testing

Study of STA-9090, Administered Once-Weekly in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Synta Pharmaceuticals Corp. 53
Testing effectiveness (Phase 2)WithdrawnNCT03059615
What this trial is testing

A Phase 2a, Open-Label, Two Stage Study of Nerofe or Nerofe With Doxorubicin in Subjects With AML or MDS

Who this might be right for
Acute Myelogenous LeukemiaMyelodysplastic Syndromes
Immune System Key Ltd
Early research (Phase 1)Study completedNCT01189968
What this trial is testing

Carboplatin and Pemetrexed Plus Demcizumab (OMP-21M18) in Subjects With Non-Squamous Non-Small Cell Lung Cancer

Who this might be right for
Non Small Cell Lung Cancer
OncoMed Pharmaceuticals, Inc. 50
Not applicableWithdrawnNCT02139150
What this trial is testing

Serial FLT PET Imaging in Cancer Patients for Monitoring of Response to Therapy

Who this might be right for
Histologically-confirmed Malignancies
Memorial Sloan Kettering Cancer Center
Post-approval studies (Phase 4)Study completedNCT03226119
What this trial is testing

MP Diagnostics HTLV Blot 2.4 Post-Market Clinical Study

Who this might be right for
HTLV-I InfectionsHTLV-II InfectionsHuman T-lymphotropic Virus 1+3 more
MP Biomedicals, LLC 150
Early research (Phase 1)Study completedNCT05155709
What this trial is testing

Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy.

Who this might be right for
Acute Myeloid Leukemia
Novartis Pharmaceuticals 14
Large-scale testing (Phase 3)Looking for participantsNCT06750419
What this trial is testing

89Zr-TLX250 for PET/CT Imaging of ccRCC - ZIRCON-CP Study

Who this might be right for
Clear Cell Renal Cell Carcinoma
Telix Pharmaceuticals (Innovations) Pty Limited 82
Not applicableEnrolling By InvitationNCT07724028
What this trial is testing

Neurovascular Bundle Stimulation During Robot-Assisted Radical Prostatectomy

Who this might be right for
Histologically Confirmed Localized Prostate CancerScheduled to Undergo Robot-assisted Radical Prostatectomy With Planned Unilateral or Bilateral Nerve-sparing Surgery
University Medical Centre Ljubljana 20
Testing effectiveness (Phase 2)Study completedNCT00171587
What this trial is testing

Study of the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Effects of Vatalanib in Combination With Capecitabine in Patients With Advanced Cancer

Who this might be right for
TumorsNeoplasm Metastasis
Novartis 22
Not applicableNot Yet RecruitingNCT07366892
What this trial is testing

Leica Microsystems Sponsored PMCF Study to Collect and Confirm Clinical Data on the Performance of the GLOW400 Device When Used in Accordance With Its Intended Use

Who this might be right for
Suspected Grade III and IV Gliomas Requiring Surgical InterventionNeurosurgical ProcedureGlioma+1 more
Leica Microsystems (Schweiz) AG 37
Large-scale testing (Phase 3)Ended earlyNCT06125028
What this trial is testing

[68Ga]Ga-PentixaFor-PET Imaging for Staging of Marginal Zone Lymphoma

Who this might be right for
Marginal Zone Lymphoma
Pentixapharm AG 8
Testing effectiveness (Phase 2)Study completedNCT04338867
What this trial is testing

Nitroglycerin Plus Intracranial Radiotherapy for Brain Metastases in NSCLC Patients

Who this might be right for
Phase II Clinical TrialNinety-six Histologically Confirmed NSCLC Patients With BMRandomized 1:1 to Received TN Plus WBR or Only WBR+1 more
Instituto Nacional de Cancerologia de Mexico 96
Early research (Phase 1)Study completedNCT01324479
What this trial is testing

Study of INC280 in Patients With c-MET Dependent Advanced Solid Tumors

Who this might be right for
Solid Tumors
Novartis Pharmaceuticals 131
Not applicableNot Yet RecruitingNCT07341542
What this trial is testing

A Prospective Clinical Study Investigating the Use of the Histolog Scanner for Intraoperative Assessment of Surgical Margins in Patients Undergoing Breast-conserving Surgery for Histologically Confirmed Breast Cancer. The Histolog Scanner Operates on the Principle of Confocal Microscop

Who this might be right for
Breast Cancer
Silesian Hospital in Opava 20
Early research (Phase 1)Ended earlyNCT01548924
What this trial is testing

Determination of Dose of Antiangiogenic Multitargeted DOVITINIB (TKI258) Plus Paclitaxel in Patients With Solid Tumors

Who this might be right for
Solid Tumors
Centro Nacional de Investigaciones Oncologicas CARLOS III 13
Testing effectiveness (Phase 2)WithdrawnNCT04665115
What this trial is testing

Ibrutinib for the Treatment of Patients With B-Cell Malignancies Who Are Infected With Coronavirus Disease 2019 (COVID-19)

Who this might be right for
Asymptomatic COVID-19 Infection Laboratory-ConfirmedB-Cell NeoplasmChronic Lymphocytic Leukemia+6 more
Academic and Community Cancer Research United
Testing effectiveness (Phase 2)Looking for participantsNCT06097468
What this trial is testing

Nisin in Oral Cavity Squamous Cell Carcinoma (OCSCC)

Who this might be right for
Oral Cavity Squamous Cell Carcinoma
University of California, San Francisco 40
Early research (Phase 1)Active Not RecruitingNCT07584668
What this trial is testing

Safety, Tolerability and Pharmacokinetics of EM-I-2024

Who this might be right for
Assess the Safety and Tolerability of Various Doses and Dosing Schedules of EnteroMix in Patients With a Histologically Confirmed Solid Tumor
National Medical Research Radiological Centre of the Ministry of Health of Russia 24
Next Page